vs

Side-by-side financial comparison of ISABELLA BANK CORP (ISBA) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $21.2M, roughly 2.0× ISABELLA BANK CORP). ISABELLA BANK CORP runs the higher net margin — 22.2% vs -17.2%, a 39.4% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs 14.3%). ISABELLA BANK CORP produced more free cash flow last quarter ($23.3M vs $692.0K). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 12.6%).

The Bank of the Philippine Islands is a universal bank in the Philippines. It is the oldest bank in both the Philippines and Southeast Asia. It is the fourth largest bank in terms of assets, the second largest bank in terms of market capitalization, and one of the most profitable banks in the Philippines.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

ISBA vs STIM — Head-to-Head

Bigger by revenue
STIM
STIM
2.0× larger
STIM
$41.8M
$21.2M
ISBA
Growing faster (revenue YoY)
STIM
STIM
+71.5% gap
STIM
85.7%
14.3%
ISBA
Higher net margin
ISBA
ISBA
39.4% more per $
ISBA
22.2%
-17.2%
STIM
More free cash flow
ISBA
ISBA
$22.6M more FCF
ISBA
$23.3M
$692.0K
STIM
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
12.6%
ISBA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ISBA
ISBA
STIM
STIM
Revenue
$21.2M
$41.8M
Net Profit
$4.7M
$-7.2M
Gross Margin
52.0%
Operating Margin
32.2%
-12.1%
Net Margin
22.2%
-17.2%
Revenue YoY
14.3%
85.7%
Net Profit YoY
17.4%
43.2%
EPS (diluted)
$0.64
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ISBA
ISBA
STIM
STIM
Q4 25
$21.2M
$41.8M
Q3 25
$20.5M
$37.3M
Q2 25
$18.8M
$38.1M
Q1 25
$18.1M
$32.0M
Q4 24
$18.5M
$22.5M
Q3 24
$18.0M
$18.5M
Q2 24
$17.2M
$16.4M
Q1 24
$16.7M
$17.4M
Net Profit
ISBA
ISBA
STIM
STIM
Q4 25
$4.7M
$-7.2M
Q3 25
$5.2M
$-9.0M
Q2 25
$5.0M
$-10.1M
Q1 25
$3.9M
$-12.7M
Q4 24
$4.0M
$-12.7M
Q3 24
$3.3M
$-13.3M
Q2 24
$3.5M
$-9.8M
Q1 24
$3.1M
$-7.9M
Gross Margin
ISBA
ISBA
STIM
STIM
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Q1 24
75.1%
Operating Margin
ISBA
ISBA
STIM
STIM
Q4 25
32.2%
-12.1%
Q3 25
30.7%
-19.6%
Q2 25
32.8%
-21.1%
Q1 25
26.9%
-34.4%
Q4 24
26.0%
-51.0%
Q3 24
21.3%
-41.7%
Q2 24
23.9%
-51.7%
Q1 24
21.8%
-39.4%
Net Margin
ISBA
ISBA
STIM
STIM
Q4 25
22.2%
-17.2%
Q3 25
25.6%
-24.3%
Q2 25
26.7%
-26.6%
Q1 25
21.9%
-39.6%
Q4 24
21.6%
-56.4%
Q3 24
18.2%
-72.0%
Q2 24
20.3%
-59.8%
Q1 24
18.7%
-45.2%
EPS (diluted)
ISBA
ISBA
STIM
STIM
Q4 25
$0.64
$-0.10
Q3 25
$0.71
$-0.13
Q2 25
$0.68
$-0.15
Q1 25
$0.53
$-0.21
Q4 24
$0.54
$-0.34
Q3 24
$0.44
$-0.44
Q2 24
$0.46
$-0.33
Q1 24
$0.42
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ISBA
ISBA
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$26.0M
$28.1M
Total DebtLower is stronger
$65.8M
Stockholders' EquityBook value
$231.4M
$22.4M
Total Assets
$2.2B
$141.6M
Debt / EquityLower = less leverage
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ISBA
ISBA
STIM
STIM
Q4 25
$26.0M
$28.1M
Q3 25
$161.3M
$28.0M
Q2 25
$108.6M
$11.0M
Q1 25
$69.2M
$20.2M
Q4 24
$24.5M
$18.5M
Q3 24
$27.4M
$20.9M
Q2 24
$23.6M
$42.6M
Q1 24
$25.2M
$47.7M
Total Debt
ISBA
ISBA
STIM
STIM
Q4 25
$65.8M
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$59.8M
Q1 24
$59.4M
Stockholders' Equity
ISBA
ISBA
STIM
STIM
Q4 25
$231.4M
$22.4M
Q3 25
$227.4M
$27.4M
Q2 25
$220.5M
$27.1M
Q1 25
$215.6M
$35.5M
Q4 24
$210.3M
$27.7M
Q3 24
$213.0M
$9.4M
Q2 24
$202.2M
$19.4M
Q1 24
$200.7M
$27.7M
Total Assets
ISBA
ISBA
STIM
STIM
Q4 25
$2.2B
$141.6M
Q3 25
$2.3B
$145.5M
Q2 25
$2.2B
$134.7M
Q1 25
$2.1B
$142.0M
Q4 24
$2.1B
$140.9M
Q3 24
$2.1B
Q2 24
$2.1B
$96.8M
Q1 24
$2.1B
$103.8M
Debt / Equity
ISBA
ISBA
STIM
STIM
Q4 25
2.94×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
3.08×
Q1 24
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ISBA
ISBA
STIM
STIM
Operating Cash FlowLast quarter
$26.8M
$908.0K
Free Cash FlowOCF − Capex
$23.3M
$692.0K
FCF MarginFCF / Revenue
110.2%
1.7%
Capex IntensityCapex / Revenue
16.4%
0.5%
Cash ConversionOCF / Net Profit
5.72×
TTM Free Cash FlowTrailing 4 quarters
$36.0M
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ISBA
ISBA
STIM
STIM
Q4 25
$26.8M
$908.0K
Q3 25
$2.7M
$-785.0K
Q2 25
$7.8M
$-3.5M
Q1 25
$4.7M
$-17.0M
Q4 24
$19.6M
$-8.6M
Q3 24
$3.6M
$-5.4M
Q2 24
$5.5M
$-5.0M
Q1 24
$3.4M
$-12.0M
Free Cash Flow
ISBA
ISBA
STIM
STIM
Q4 25
$23.3M
$692.0K
Q3 25
$1.7M
$-899.0K
Q2 25
$7.2M
$-3.8M
Q1 25
$3.7M
$-17.2M
Q4 24
$17.5M
$-8.7M
Q3 24
$3.2M
$-5.8M
Q2 24
$5.1M
$-5.6M
Q1 24
$2.6M
$-12.4M
FCF Margin
ISBA
ISBA
STIM
STIM
Q4 25
110.2%
1.7%
Q3 25
8.5%
-2.4%
Q2 25
38.5%
-9.9%
Q1 25
20.6%
-53.8%
Q4 24
94.6%
-38.6%
Q3 24
17.7%
-31.3%
Q2 24
29.8%
-34.0%
Q1 24
15.7%
-71.1%
Capex Intensity
ISBA
ISBA
STIM
STIM
Q4 25
16.4%
0.5%
Q3 25
5.0%
0.3%
Q2 25
3.2%
0.7%
Q1 25
5.5%
0.7%
Q4 24
11.4%
0.4%
Q3 24
2.0%
2.1%
Q2 24
2.4%
3.7%
Q1 24
4.9%
2.2%
Cash Conversion
ISBA
ISBA
STIM
STIM
Q4 25
5.72×
Q3 25
0.52×
Q2 25
1.56×
Q1 25
1.19×
Q4 24
4.91×
Q3 24
1.08×
Q2 24
1.59×
Q1 24
1.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons